Bempedoic acid/ezetimibe - Esperion Therapeutics
At a glance
- Drug Originator Esperion Therapeutics
- Drug Licenced by Daiichi Sankyo Europe; Otsuka Pharmaceutical
- Drug Class Antihyperlipidaemics; Azetidines; Dicarboxylic acids; Fatty acids; Fluorobenzenes; Propanols; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; ATP citrate (pro S) lyase inhibitors; Cholesterol absorption inhibitors; Cholesterol synthesis inhibitors; NPC1L1 protein inhibitors; Peroxisome proliferator-activated receptor agonists
- USA Patent Applicants ESPERION THERAPS INC
- USA Patents 24
- NDAs 1
- International Patents 70
Table of Contents

Disclaimer